- Home
- ALLO vs TASK Comparison
ALLO vs TASK Comparison
Compare ALLO & TASK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALLO | TASK |
|---|---|---|
| Founded | 2017 | 2008 |
| Country | United States | United States |
| Employees | 152 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 722.1M | 598.9M |
| IPO Year | 2018 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ALLO | TASK |
|---|---|---|
| Price | $2.09 | $7.88 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 15 | 5 |
| Target Price | $8.35 | ★ $14.70 |
| AVG Volume (30 Days) | ★ 5.9M | 980.8K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 34.09 | ★ 120.00 |
| EPS | N/A | ★ 0.50 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $5.95 |
| Revenue Next Year | $142,416.42 | $6.46 |
| P/E Ratio | ★ N/A | $15.52 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.04 | $4.47 |
| 52 Week High | $4.46 | $18.39 |
Technical Indicators
Market Signals| Indicator | ALLO | TASK |
|---|---|---|
| Relative Strength Index (RSI) | 54.73 | 63.32 |
| Support Level | $2.07 | $6.30 |
| Resistance Level | $2.25 | $8.23 |
| Average True Range (ATR) | 0.11 | 0.48 |
| MACD | 0.02 | 0.07 |
| Stochastic Oscillator | 65.85 | 81.20 |
Price Performance
Historical ComparisonAbout ALLO Allogene Therapeutics Inc.
Allogene Therapeutics Inc is a clinical stage immuno-oncology company pioneering the development of genetically engineered allogeneic T cell product candidates for the treatment of cancer and autoimmune diseases. Its pipeline includes "off-the-shelf" T cell candidates designed to target cancer cells or eliminate autoreactive cells in patients with autoimmune disorders. Its three core programs are: Large B-Cell Lymphoma (LBCL), Autoimmune Disease (AID) and Renal Cell Carcinoma (RCC).
About TASK TaskUs Inc.
TaskUs Inc provides outsourced digital services. Its service offerings include Digital Customer Experience consists of omnichannel customer care services, delivered through digital (non-voice) channels, also including learning experience and sales and customer acquisition services; Trust & Safety consists of monitoring, reviewing and managing user and advertiser-generated content on online platforms to ensure it complies with community guidelines, legal regulations and platform specific policies; and AI Services consists of large language model support and high-quality data labeling services, annotation, context relevance and transcription services performed for the purpose of training and tuning machine learning algorithms, enabling them to develop cutting-edge AI systems.